Variant report
Variant | nsv518679 |
---|---|
Chromosome Location | chr9:9119327-9125205 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550500669 | chr9:9120209-9120210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572731382 | chr9:9120223-9120224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550208519 | chr9:9120248-9120249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568706340 | chr9:9120254-9120255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535888594 | chr9:9120265-9120266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147732706 | chr9:9120282-9120283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183960697 | chr9:9120327-9120328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371968664 | chr9:9120347-9120348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546156868 | chr9:9120365-9120366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558243712 | chr9:9120451-9120452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189989972 | chr9:9120458-9120459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543575848 | chr9:9120482-9120483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555390718 | chr9:9120501-9120502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192862136 | chr9:9120505-9120506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540651975 | chr9:9120533-9120534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558920102 | chr9:9120553-9120554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532901804 | chr9:9120564-9120565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185376264 | chr9:9120589-9120590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563347241 | chr9:9120602-9120603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576321666 | chr9:9120603-9120604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531831764 | chr9:9120625-9120626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550335303 | chr9:9120626-9120627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562274411 | chr9:9120660-9120661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529612104 | chr9:9120676-9120677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149217102 | chr9:9120709-9120710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566089244 | chr9:9120714-9120715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77441735 | chr9:9120719-9120720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551606310 | chr9:9120741-9120742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190248765 | chr9:9120756-9120757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536881710 | chr9:9120821-9120822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555515694 | chr9:9120829-9120830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573898467 | chr9:9120843-9120844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35626722 | chr9:9120849-9120850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534595749 | chr9:9120853-9120854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552805689 | chr9:9120866-9120867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs143415496 | chr9:9120945-9120946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544573878 | chr9:9120955-9120956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148347507 | chr9:9121017-9121018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182431255 | chr9:9121044-9121045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186587487 | chr9:9121045-9121046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76377517 | chr9:9121078-9121079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559236694 | chr9:9121143-9121144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528324522 | chr9:9121149-9121150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560061856 | chr9:9121159-9121160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533381275 | chr9:9121182-9121183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141538814 | chr9:9121201-9121202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570079050 | chr9:9121204-9121205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75050570 | chr9:9121265-9121266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9886879 | chr9:9121312-9121313 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs188248074 | chr9:9121325-9121326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9120200-9120400 | Enhancers | Fetal Brain Female | brain |
2 | chr9:9120400-9120600 | Enhancers | Sigmoid Colon | Sigmoid Colon |
3 | chr9:9120400-9122600 | Weak transcription | Fetal Brain Female | brain |
4 | chr9:9122000-9123200 | Enhancers | Fetal Brain Male | brain |
5 | chr9:9122600-9123000 | Enhancers | Fetal Brain Female | brain |
6 | chr9:9123200-9127000 | Weak transcription | Pancreas | Pancrea |
7 | chr9:9123200-9127400 | Weak transcription | Fetal Brain Male | brain |
8 | chr9:9124400-9125000 | Enhancers | Fetal Kidney | kidney |
9 | chr9:9125000-9125400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |